1 year return (CAGR)
-10.31%
Inozyme Pharma Inc Exchange (NASDAQ, USD)
INZY
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-8.14%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
258.25M
Price/Sales
130.69
Ent value
294.25M
Price/Book
3.12
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 4.00 |
| Daily high | 4.00 |
| Daily low | 4.00 |
| Daily Volume | 0K |
| 1y analyst estimate | 4.00 |
| Beta | 2.29 |
| EPS (TTM) | -1.52 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| INZY | S&P500 | |
| Current price drop from All-time high | -86.75% | -0.17% |
| Highest price drop | -97.28% | -56.47% |
| Date of highest drop | 4 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -72.39% | -10.68% |
| Avg time to new high | 113 days | 12 days |
| Max time to new high | 1214 days | 1805 days |
News
No items found